Seeking Alpha

Curis (CRIS -3.8%) trades lower today, despite the company's earlier announcement that it's been...

Curis (CRIS -3.8%) trades lower today, despite the company's earlier announcement that it's been issued a patent covering a genus of compounds that includes Debio 0932, an orally-administered Heat Shock Protein 90 inhibitor, which is being developed by Curis' licensee Debiopharm.
Comments (1)
  • foldholder
    , contributor
    Comments (92) | Send Message
     
    is the downside just profit taking?
    6 Dec 2012, 03:24 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|